| 1.68 Data as of Jun 19 |  -0.09 / -5.08%Today’s Change | 0.62 Today|||52-Week Range 2.67 | +3.07% Year-to-Date |
| Previous close | 1.77 |
| Today’s open | 1.75 |
| Day’s range | 1.68 - 1.79 |
| Volume | 687,939 |
| Average volume (3 months) | 321,801 |
| Market cap | $69.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +34.00% |
| Earnings growth (this year) | +39.90% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +12.07% |
| P/E ratio | NM |
| Price/Sales | 34.35 |
| Price/Book | 4.75 |
| Today’s change | Today’s % change | |
|---|---|---|
| MAXYMaxygen Inc | -0.01 | -0.40% |
| ARWRArrowhead Research C... | +0.01 | +0.50% |
| PBMDPrima BioMed Ltd | +0.03 | +1.34% |
| ENMDEntreMed Inc | -0.03 | -1.49% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $1.4M |
| Annual profit (last year) | -$28.5M |
| Net profit margin | -2,082.76% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Martin M. McGlynn |
Chief Financial Officer & VP-Administration Rodney K. B. Young, MBA |
Corporate headquarters Newark, California |
.
